# A New Glucose Meter With Alternative Site Testing

> **NCT00797212** · NA · COMPLETED · sponsor: **Ascensia Diabetes Care** · enrollment: 50 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DEVICE:** Apollo Blood Glucose Monitoring System

## Key facts

- **NCT ID:** NCT00797212
- **Lead sponsor:** Ascensia Diabetes Care
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2016-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00797212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00797212, "A New Glucose Meter With Alternative Site Testing". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00797212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*